The stock of AmerisourceBergen Corporation (NYSE:ABC) last traded at $170.17, down -0.52% from the previous session.
Data from the available sources indicates that AmerisourceBergen Corporation (NYSE:ABC) is covered by 18 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $207.00 and a low of $172.00, we find $190.00. Given the previous closing price of $171.06, this indicates a potential upside of 11.07 percent. ABC stock price is now 3.16% away from the 50-day moving average and 7.99% away from the 200-day moving average. The market capitalization of the company currently stands at $34.74B.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
In total, 5 analysts have assigned it a hold rating, and 11 have given it a buy rating. Brokers who have rated the stock have averaged $189.13 as their price target over the next twelve months.
In other news, Campbell Elizabeth S, Executive Vice President sold 7,500 shares of the company’s stock on May 17. The stock was sold for $1,305,884 at an average price of $174.12. Upon completion of the transaction, the Executive Vice President now directly owns 11,893 shares in the company, valued at $2.02 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 11, 10% Owner Walgreens Boots Alliance, Inc. sold 292,792 shares of the business’s stock. A total of $50,000,090 was realized by selling the stock at an average price of $170.77. This leaves the insider owning 33,366,388 shares of the company worth $5.68 billion. Insiders disposed of 19,570,602 shares of company stock worth roughly $3.33 billion over the past 1 year. A total of 0.20% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ABC stock. A new stake in AmerisourceBergen Corporation shares was purchased by UBS ASSET MANAGEMENT AMERICAS INC during the first quarter worth $159,727,000. POINT72 ASSET MANAGEMENT, L.P. invested $65,567,000 in shares of ABC during the first quarter. In the first quarter, AVIDITY PARTNERS MANAGEMENT LP acquired a new stake in AmerisourceBergen Corporation valued at approximately $21,544,000. HBK SORCE ADVISORY LLC acquired a new stake in ABC for approximately $8,262,000. PROSHARE ADVISORS LLC purchased a new stake in ABC valued at around $7,358,000 in the second quarter. In total, there are 1,346 active investors with 72.40% ownership of the company’s stock.
With an opening price of $170.07 on Thursday morning, AmerisourceBergen Corporation (NYSE: ABC) set off the trading day. During the past 12 months, AmerisourceBergen Corporation has had a low of $135.14 and a high of $176.62. As of last week, the company has a debt-to-equity ratio of 17.51, a current ratio of 0.90, and a quick ratio of 0.50. According to the stock market information, the enterprise value for the company is $38.17B, which is based on a 21.86 price-to-earnings ratio, a 2.71 price-to-earnings-growth ratio, and a beta of 0.52. The fifty day moving average price for ABC is $165.37 and a two-hundred day moving average price translates $157.70 for the stock.
The latest earnings results from AmerisourceBergen Corporation (NYSE: ABC) was released for Mar, 2023. According to the Medical Distribution Company, earnings per share came in at $3.5, beating analysts’ expectations of $3.29 by 0.21. This compares to $2.62 EPS in the same period last year. The company reported revenue of $63.46 billion for the quarter, compared to $57.72 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 9.94 percent. For the current quarter, analysts expect ABC to generate $63.49B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 05/30/2023. Investors who held shares on 05/12/2023 were paid a $0.485 dividend. On an annualized basis, this represents a $1.94 dividend and a 1.14% percent yield. There was an ex-dividend date of 05/11/2023 for this dividend. In terms of dividend payout ratio, ABC is presently at 24.00%.
AmerisourceBergen Corporation(ABC) Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company’s International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
